Sentence examples for molecular abnormalities of from inspiring English sources

Meador-Woodruff, J. H., Clinton, S. M., Beneyto, M. & McCullumsmith, R. E. Molecular abnormalities of the glutamate synapse in the thalamus in schizophrenia.

Koshelev, M., Sarma, S., Price, R. E., Wehrens, X. H. T. & Cooper, T. A. Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1.

Precision medicine, where treatments are tailored to specific molecular abnormalities of tumors, holds great promise for improving outcomes in this disease.

Molecular abnormalities of human plasminogen isolated from synovial fluid of rheumatoid arthritis patients.

Molecular imaging specifically probes the molecular abnormalities of diseases to allow earlier detection, monitoring of disease progression, and molecular assessment of treatments [1].

In addition, the molecular abnormalities of inflamed colonic mucosa in CAC appear present much earlier than any histological evidence (dysplasia or cancer).

The treating physician was only informed of the result of the molecular abnormality of interest just at the time when the patient was about to start treatment with the matched MTA, being at randomization or at cross-over.

It is now well established that patients with a molecular abnormality of the telomeric domain (ICR1 hypermethylation) and 11p15 paternal uniparental disomy have an increased risk of embryonal tumors (especially Wilms' tumor), whereas patients with defects of the centromeric domain only (ICR2 hypomethylation and CDKN1C mutations) are at lower risk of such tumors.

However, the finding that only a minority of the inclusions in NIFID are IF-ir, the absence of any identifiable genetic or molecular abnormality of IF in these cases and the recognition that immunohistochemistry for IF is not specific for this condition, is consistent with the possibility that another protein may be more central to the pathogenesis.

In the current study we investigated the capacity of molecular abnormalities to increase the accuracy of disease risk stratification above that afforded by clinical staging alone.

In this study, we used AFI to enrich our biopsy samples prior to biomarker analysis since we hypothesised that these areas may correlate with a field of molecular abnormalities indicative of the overall dysplasia status of the patient and hence reduce sampling bias.